New Delhi, June 20: US researchers have found that developing personalised vaccines can play a key role in keeping aggressive tumours from recurring. The study, led by a team from the University of Wisconsin-Madison, focused on triple-negative breast cancer and melanoma, a deadly skin cancer. Currently, the long-term prognosis for human patients with these cancers.
